Medicine by Design-funded foundational technology grows into biotech success story: Notch Therapeutics closes an $85 million Series A financing

Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.

By |2021-02-11T16:40:53-05:00February 10th, 2021|Categories: News|Tags: , , , , |

Medicine by Design invests $1.2 million in new ideas to advance regenerative medicine research and translation

Nine funded projects span synthetic biology, computational modelling, immunoengineering and organoids

Go to Top